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2Introduction
With the emergence and proliferation of multi-resistant organisms, the prospect of an 
'antimicrobial perfect storm’ 1in the approaching decades has become an urgent public 
health concern.1 The excessive and indiscriminate use of these drugs in both human and 
veterinary practices has led to the emergence and dissemination of resistant organisms 
that endanger their efficacy. 2,3,4 Each year in the United States, at least 2 million people 
become infected with bacteria that are resistant to antibiotics, and at least 23,000 people 
die as a direct result of these infections. 5 Warning of an approaching era in which 
antibiotics will no be longer effective, the World Health Organisation (WHO) and other 
agencies 6,7 suggest alternative approaches, including the development of novel therapies  
to treat both mild and serious infections. 7,8 With a growing body of clinical evidence, a 
strong safety record and evidence of cost-effectiveness, 9–11 homeopathy represents one 
potential therapeutic solution that could lead to a reduction in the use of antibiotics. 
Acute upper respiratory tract infections (URTIs) account for 60% of antibiotic 
prescribing in primary care, 12 yet they provide little benefit for the large proportion of 
respiratory tract infections which are viral in origin. This review of the literature asks 
firstly, whether the peer review literature on this topic is sufficiently robust for 
homeopathy to be seriously considered as an alternative to antibiotics for upper 
respiratory tract infections (URTIs) and their complications and secondly, how this 
homeopathic intervention might take place, for example through more widespread use of 
particular homeopathic preparations. 
Literature search strategy
The literature review focuses on peer-reviewed clinical studies featuring homeopathic 
treatment of upper respiratory tract infections published after 1994. Due to the close 
association between URTIs and acute rhino-pharyngitis and tonsillitis and their frequent 
treatment with antibiotics, a number of peer review studies in which homeopathy was 
used to treat these conditions were also reviewed. Although not rigorously following 
format of a systematic review, the PRISMA guidelines (http://www.prisma-
3statement.org) and recommendations of PRISMA-P checklist (http://www.prisma-
statement.org/documents/PRISMA-P-checklist.pdf) were utilised for the reporting of data 
on tables one and two. Searches were conducted in two phases. In phase one, the 
following electronic databases were searched: AMED, Embase, Cochrane Library, 
Pubmed, ScienceDirect, Elsevier Health periodicals and CORE-Hom database. In phase 
two, additional searches were performed through Google Scholar, Mendeley literature 
search and the author’s university library. Citation chaining was also utilized, however 
studies for which the full paper or key study details could not be later established were 
excluded from the final systematic analysis. Searches, although wide, were limited to 
published, peer reviewed human trials reported in English. Key search terms were: 
homeopathy, upper respiratory tract infections, rhinopharyngitis and mild viral infections. 
Studies which included related conditions, such as bronchitis, 13 influenza, 14 otitis media 
and tonsillitis 15 were considered only if upper respiratory tract infection, or viral 
infection involving the upper respiratory tract was mentioned in the title or aims, and 
where relevant to the study questions. Further exclusion criteria included studies deemed 
to be of poor quality, published before 1994 and where more than one CAM therapy was 
used. Case reports of homeopathic treatments for upper respiratory tract infections from 
books and journals were also not considered. To ensure that a broad body of evidence 
was considered, peer reviewed published studies, whether randomised, controlled or 
cohort, were reviewed, but were considered separately in terms of study aims and design 
(see table one). Analysis of all studies focused on the following elements: trial design; 
treatment invention, with particular reference to single/complex homeopathic 
medicaments (see table two); cohort group (paediatric/adult/ both); measurement criteria, 
and; outcome, with particular reference to reduction in antibiotic use. 
URTIs and antibiotics
The upper respiratory tract (URT) consists of the nose, mouth, throat, larynx and trachea. 
Upper respiratory tract infection (URTI) it is the most common infectious illness in most 
populations and the primary reason people miss work or school. 16 Although generally 
short lived, symptoms of URTIs such as fever, sore throat, headache and cough are 
sources of distress for both adults and children and are costly in terms of time off work 
417,18
 and school. 18 The acute cough following a URTI can continue for several weeks.13 
Children are especially susceptible, and may have as many as 8 or even more episodes
 
each year. Most URTIs are caused by a self-limiting viral illness (such as influenza and 
rhinoviruses) with symptoms lasting 7-10 days however complications such otitis media, 
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 pharyngitis, 20 tonsillitis 21 and sinusitis 22  are frequently treated with antibiotics. 23–27 
In the US, 23% of paediatric medical visits from 2004-8 resulted in prescriptions for 
antibiotics 28 with otitis media the most common reason for prescribing antibiotics in 
children. Other pharmacological treatments include antipyretics, anti-inflammatory drugs, 
expectorants, decongestants, and cough suppressants, either alone or in combination. 29 
Respiratory complaints are also the most frequent reason for over the counter (OTC) 
purchases of homeopathic medicines, 30 suggesting a demand for alternatives to 
pharmaceutical OTC products.
Public health and medical stewardship programs aim to alter patients’ perceptions and 
doctors' prescribing behaviour. 1 Yet in many clinical contexts, antibiotic prescribing 
continues to elude best practice, 1 including in the treatment of URTIs and URTI related  
conditions. 31,32,33 According to a recent US clinical report, up to 10 million antibiotic 
prescriptions per year directed toward respiratory conditions were unlikely to provide any 
benefit. 34 Fewer than 10% of sore throats are caused by bacterial infections, yet in 
around 60% of cases, antibiotics were prescribed for them. 35 In recent Cochrane reviews 
the short-term effects of antibiotics on acute otitis media (AOM) 36 and URTIs 37 were 
moderate or negligible when compared to their potential risks. One Cochrane study found 
antibiotics be ‘not very useful’ in the treatment of AOM, only marginally decreasing the 
number of children with pain at 24 hours (when most children were better), only slightly 
reducing those with pain in the few days following infection and having no effect on 
reducing the number of children with subsequent hearing loss. 36 In some patients with 
acute bronchitis, antibiotics had a modest beneficial effect, however these benefits must 
be considered in the broader context of side effects, the self-limiting nature of the 
condition, the costs of antibiotic treatment and the increased resistance to respiratory 
pathogens. 37 Only in the case of pneumonia in the elderly were the benefits of antibiotics 
seen as significant, 38 however the authors of this study concluded that the use of 
5antibiotics for prophylaxis was still not justifiable. Another US study estimated the 
number of annual antibiotic prescriptions for acute respiratory conditions (including 
sinusitis, otitis media, and pharyngitis) as 221 per 1000 people, yet only half of these 
prescriptions were considered appropriate for these conditions. 39 Understanding 
differential diagnosis is also important, as is ruling out more serious illness. For instance, 
while most cases of acute pharyngitis in children have a viral origin, are benign and self-
limiting, (and for which antibiotics are often unnecessarily prescribed), untreated 
streptococcal tonsillopharyngitis can result in serious complications, such as rheumatic 
fever and related cardiovascular disorders or post streptococcalglomerulonephritis. 40,41
In addition to efficacy, the immunological effects and safety of antibiotics is a concern. 
Studies confirm that pervasive changes occur within the human microbiome after 
antibiotic treatment and that resistant strains of bacteria can persist for years. 42 
Individuals prescribed antibiotics in primary care for a respiratory infection develop 
bacterial resistant to that antibiotic, which not only increases the population carriage of 
organisms resistant to first line antibiotics, but leads to increased use of second line 
antibiotics in the community. 43 According to one meta-analysis, the risk of acquiring 
methicillin-resistant Staphylococcus aureus increased by 1.8-fold in patients, who had 
taken antibiotics. 44 Nevertheless, public awareness concerning the appropriate use and 
safety of antibiotics still appears to be lacking. In one Australian consumer study, over a 
third of the 252 participants thought that taking antibiotics when suffering from a cold or 
flu would lead to more rapid recovery, while nearly one-fifth considered antibiotics as a 
cure for viral infections. 45 Links have been established between antibiotic use and 
paediatric asthma 46,47 and eczema 48 and less common but grave physical and 
psychoactive side effects associated with particular antibiotics. The class of antibiotics 
fluoroquinolones are known to cause tendonitis, CNS effects, peripheral neuropathy,49 
and juvenile fluoroquinolone-induced joint/cartilage toxicity. 50 Severe side effects of the 
broad spectrum antibiotic Clarithromycin include liver and renal failure 51,52 and psycho-
neurological effects including hallucinations, depersonalization, depression, insomnia and 
psychosis. 53  
6The homeopathic approach
As a CAM therapy, homeopathy has been subject to criticism for its use of infinitesimal 
doses to treat different aliments, with insufficient proof that such doses can have an 
effect. 54 Yet, despite a long history of scientific controversy, homeopathy has proved 
resilient, is geographically widespread 55 and is an accepted part of the medical system in 
countries such as India, 56 France 57 and Switzerland. 58 Advantages of homeopathy 
include ease of application and safety, with few contraindications existing in the 
treatment of the very young 28 and old, beside the careful selection of remedy and dosage. 
Whereas using antibiotics and over the counter medications does little to improve the 
body’s future response to infection, homeopathy purports to do so.
When dealing with complex systems, a holistic medical approach, such as is frequently 
used in homeopathy, can offer therapeutic advantages over non-individualised 
reductionist methods. 59,60 In part it is the person focused approach of traditional 
homeopathy that distinguishes it from conventional approaches 61 and contributes to its 
appeal to certain population groups. 62–64 Unlike mainstream medicine, where treatment is 
based on the clinical diagnosis and the idiosyncratic symptoms of the patient are given 
less importance, in the ‘classical’ homeopathic tradition the prescription of a 
homeopathic medication or ‘remedy’ is based on the totality of symptoms and signs 
exhibited or expressed by an individual patient. 65 Thus in homeopathic case-taking the 
assessment of the medical situation may not be the principle reason for the choice of 
remedy 58 and a spectrum of remedies based on different criteria may be considered. 
There are, however, many variations to the homeopathic method of prescribing, 
especially in the treatment of chronic conditions. A particular distinction lies between 
individualised and clinically based homeopathic treatment protocols, the former being 
based on a ‘total system approach’ as described above and the latter on a more generic 
method, in which ‘combination’ or ‘complex’ homeopathic medicines may be prescribed 
for a particular condition or disease. 66 Another method, ‘isopathy,’ refers to the use of 
diseased byproducts or tissues known as ‘nosodes,’ and healthy animal tissue, referred to 
as sarcodes, 67 which may be prescribed individually or to a population group for 
7preventative purposes. 68,69 All of these methodologies have been employed in clinical 
studies, including for the treatment of UTRIs. From the homeopathic perspective, patients 
with chronic conditions may require ‘constitutional’ remedies, emphasising the suitability 
of the in depth individualised approach. Seeking a ‘totality’ of symptoms in a holistic 
sense 70 is resource and time consuming however, as it requires a detailed chronological 
history of the patient and their condition so that a single remedy can be prescribed to treat 
a range of symptoms. In acute conditions the symptom picture is less complicated and the 
need to prescribe more urgent, strengthening the case for non-individualised prescribing.
Homeopathy and research
With an empirical tradition going back more than 200 years, and homeopathic physicians 
trained in the scientific method, research has always been the backbone of homeopathy. 
Homeopathic literature includes as a vast number of published drug ‘provings,’ case 
studies and practice reports, however substantial areas of practice have remained 
uncharted, for instance the treatment of large-scale epidemics have never been 
systematically and scientifically researched. 58 The problems of measuring the effects of 
homeopathic treatment through randomised controlled trials (RCTs) and other 
reductionist methods are considerable. A number of systematic reviews of the 
homeopathy RCT literature by Mathie et al 66,71,72 found significant inadequacies, with 
the majority of studies demonstrating uncertain or high risk of bias. Some studies were 
not properly randomise, with most studies addressing a different aspect of homeopathic 
care. 73 Practical problems of RCTs include selecting patients for participation, the 
insecurities caused by blinding and variations in the level of training of individual 
homeopathic physicians. Whereas conventional medicine examines the specific effect of 
a pharmaceutical substance, the effects of a homeopathic substance arise from its 
complex individual interaction with the organism and this limits the external validity and 
generalizability of placebo-controlled, blinded homeopathy studies.58 As with all clinical 
trials, there are variations in size and outcome measures with the limited number of 
homeopathic studies making these types of anomaly more significant. 
The absence of positive or any RCT results does not necessarily mean that a treatment is 
8ineffective, and a danger lies in eliminating treatments on the basis of no RCT proof of 
their efficacy. 58 Non-randomised controlled trials and patient reported surveys are 
considered by some to be inferior forms of research evidence, but are important adjuncts 
to RCTs which can measure key markers such as patient satisfaction, quality of life and 
functional health. Observational studies such as clinical outcome studies and case reports, 
monitoring the effects of homeopathy in real-life clinical settings, are a helpful adjunct to 
randomised controlled trials 74 and more closely reflect real life experiences of patients 
and physicians than RCTs, 75 and are therefore considered in this study. 
Results
Searches of online libraries and bibliographical references found multiple peer review 
studies (in English and non-English) published between 1994 and 2017, in which 
homeopathy had been used to treat upper respiratory tract infections and associated 
symptoms (cough, pharyngitis, tonsillitis, otitis media, acute sinusitis etc.). Both 
randomised control trials (RCTs) and observational/cohort studies were searched and 
screened to ensure that, as many studies as possible were included in the review and its 
discussion. Non-English language studies, and those for which key study details could 
not be established, were later excluded from the final review, as were those that did not 
directly refer to UTRIs in the title or content. For the final review, 9 RCTs and 8 
observational/ cohort studies were analysed, of which 6 of the RCTs and one 
observational/ cohort trial were paediatric studies. 7 RCTs used combination remedies 
with multiple constituents. One of RCTs in these tables is featured twice as it measured 
treatment effects on two different cohorts. The first paper (Thinesse-Mallwitz et al 
(2015)) 76 reports the effects and safety of standard treatment (ST) plus a homeopathic 
compound (Iflucid), or ST only, on a mixed age cohort with a URTI. The later paper 
(Van Haselen et al (2016))29 reports the effects of ST plus a homeopathic compound 
(Iflucid), or ST only, on a paediatric cohort. Both papers have been included in the 
analysis. The two studies reported by Zanasi’s team (RCT 13 and observational 77) bear 
similarities in that the same homeopathic complex was used on both paediatric arms, 
however in the observational study one arm received antibiotics in addition to the 
homeopathic cough medicine.  
9Full details of randomised and observational studies including trial design, mode of 
homeopathic treatment (e.g. complex, individualised), cohort, outcome assessment, 
results and conclusions are given on table 1. Table 2 focuses on studies using complex 
homeopathic remedies, and a breakdown of the homeopathic constituents where this 
information was available. 
Insert tables here: 
The paper’s discussion focuses on the following areas of concern: extent to which 
homeopathy is used for URTIs; tolerability and rate of improvement of homeopathic 
treatment; complications of URTIs; prophylactic and long-term effects; the use of 
combination versus single homeopathic remedies. As a literature review, rather than a 
systematic review, no attempt has been made to extract new data from the primary 
papers, or to assess the intrinsic quality of each study, including risk of bias.
Use of Homeopathy for UTRIs
Respiratory infections are a common reason for seeking homeopathic care. 78,79 For 
example, out of 551 paediatric patients treated at a homeopathic clinic in Rossi et al’s 
(2010) observational study, 337 presented (61%) presented with respiratory infections, 
making this the most frequently observed disease in this population group. 80 Of the 
various clinical trials featuring the use of homeopathy for a specific condition, those 
concerning infectious diseases of the upper respiratory tract, 13,29,81,82 and complications 
such as acute otitis media (ear infections) 9,83 contain some of the most positive evidence 
of the effectiveness of homeopathic interventions. 58 The evaluation of 27 studies for a 
Health Technology Assessment report on effectiveness, cost effectiveness and 
appropriateness of homeopathy on upper respiratory tract infections and allergic reactions 
showed a positive overall result in favour of homeopathy, with 6 out of 7 controlled 
studies showing at least equivalence to conventional medical interventions.58
Tolerability 
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In the treatment of self-limiting acute conditions such URTIs and mild infections, both 
treatment tolerability and the rate of improvement with a medical intervention are 
important and a number of studies suggest that homeopathic treatment can fulfil both 
these prerequisites. Many participants in homeopathic studies are children 9,81,83–87 so it is 
significant that the safety and tolerability of homeopathic treatment in the trials reviewed 
was very good. 29,76,81,88 A good rate of improvement in the acute symptoms of URTI in 
those receiving homeopathic treatment was reported in all the RCTs and observational 
trials in which this was measured, however the timescale for symptom improvement 
varied, for example fever 29 improved/ resolved faster than cough. 13
In Rabe et al’s (2004) study, treatment with the homeopathic remedy complex Gripp-
Heel was perceived by patients with mild viral infections to be more successful, with 
greater tolerability and compliance than conventional treatment. 67.9% of patients were 
considered by physicians to be asymptomatic at the end of Gripp-Heel therapy, compared 
to 47.9% in the control group.89 In Zanasi’ et al’s (2014) placebo controlled RCT 87, 80 
patients were treated for acute cough with placebo or the homeopathic syrup. While 
cough scores decreased over time in each group, cough severity was significantly lower 
in the homeopathic group than in the placebo group after 4 and 7 days (p < 0.001 and p = 
0.023, respectively). A controlled multinational clinical trial conducted by Thinesse-
Mallwitz et al (2015) in Germany and the Ukraine compared the effectiveness, safety and 
tolerability of Influcid®(IFC) as an add-on treatment, with standard care (SC) alone, in 
the prevention of recurrent acute URTIs. The IFC group (265 patients) given homeopathy 
experienced significantly faster improvement than those who had received conventional 
treatment alone. 76 
Another study by Jong et al (2016) 81 measured the effectiveness, safety and tolerability 
of a homeopathic medicinal complex in the prevention of recurrent acute upper 
respiratory tract infections in children. The trial, which took place in four outpatient 
paediatric clinics, involved children under six, with a known susceptibility to acute 
URTIs. Children were randomly divided into two groups, one group receiving the 
homeopathic combination remedy CalSuli-4-02 and the other (the control group) another 
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homeopathic product, for 3 weeks. The main outcome measure was frequency of acute 
URTIs occurring within 3 and 6 months following treatment. Another outcome measure 
was a reduction in antibiotic use. Both “appetite disorder” and  “child’s activities” 
improved in both arms of the trial, but more significantly in the CalSuli-4-02 group.
While results of the above studies are disadvantaged by limited cohort size, others such 
as the large scale international comparative outcome study by Haidvogl et al (2007) 90 of 
1,577 adults and children from 8 different countries are less disputable. In this study, 
individualised homeopathy and standard care were compared in the treatment of acute 
respiratory and ear complaints. Treatment with homeopathy was associated with 
significantly faster onset of improvement in the first week, while adverse drug reactions 
occurred more frequently only in the adult group receiving conventional treatment. 
Results at 14 days were similar in both groups. The authors concluded that homeopathy 
was not inferior to conventional treatment in ear and acute respiratory infections. 
Complications of URTIs
Complications of URTIs are not the primary focus of this paper, however in clinical 
practice they remain the most common causes of antibiotic prescriptions 21,91,39 and as 
such warrant some attention in this review. Searches revealed a good number of studies 
in which homeopathy had been used for the URTI related disorders with promising 
outcomes, including acute otitis media (ear infections) 9,83,92,93, rhinopharyngitis, 94,95 
sinusitis, 96,97,98,99 and tonsillitis. 100,101 In a study by Trichard et al (2004) comparing 
homeopathic and antibiotic treatment strategies for rhinopharyngitis in children, 
homeopathy yielded significantly better results than antibiotics in terms of both medical 
effectiveness (reduced number of episodes and number of complications) and improved 
quality of life with significantly less time taken off work for parents. 94 A randomised, 
double-blind study by Friese and Zabalotnyi  (2007)96 investigated the efficacy and 
tolerability of a homeopathic combination remedy for the treatment of acute 
rhinosinusitis. 144 patients with acute rhinosinusitis were treated either with a 
homeopathic remedy (n=72) or placebo (n=72). In the treatment group, the average sum 
score dropped from initially 12.1+/-1.6 to 5.9+/-2.0 points after 7 days. In the placebo 
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group it decreased from 11.7+/-1.6 to 11.0+/-2.9 points (p<0.0001). After 21 days, 90.3% 
of the homeopathic treatment group were free from complaints, whereas in 88.9% of the 
placebo group the complaints remained unchanged or became worse. The authors 
concluded that the homeopathic product allowed an effective and tolerable treatment of 
acute rhinosinusitis. 
There have been several studies indicating the effectiveness of homeopathy for both acute 
and chronic tonsilopharangitis. Friese et al.102 (2006) performed a multicentre, 
randomised, placebo-controlled, double-blinded study on paediatric 158 patients affected 
by acute non-streptococcal tonsillitis. The study group received Tonsilotren® hourly until 
onset of improvement, then 3 times a day while the control group received placebo. 
Typical tonsillitis symptoms included swallowing difficulties, throat pain and redness, 
salivation and fever. By day 4, the study group showed a significantly higher rate of 
decrease in symptoms and than the placebo group. By day 6, 92.4% of study patients 
showed full recovery or moderate improvement, compared to the 43.1 % in the control 
group, with a deterioration rate of 3.8% in the study group against 22.8% in the control 
group.
A more recent international randomised, controlled, clinical trial of the homeopathic 
combination remedy SilAtro-5-90 (brand name Tonsilotren®) was carried out in multiple 
settings by Palm et al (2017). 101 256 patients aged 6-60 years with moderate recurrent 
tonsillitis (RT) were given either the homeopathic preparation in addition to standard 
symptomatic treatment, or standard treatment alone. The test group received 
Tonsilotren® for 3 treatment periods of 8 weeks, each treatment period being followed 
by an 8 to 12 weeks period without the homeopathic preparation. The primary outcome 
measure was the estimated rate of diagnosed acute throat infections per year with other 
outcome measures being severity of RT symptoms and the antibiotics required due to 
acute throat infections. Occurrence of RT symptoms was seen in a significantly lower 
percentage of patients in the test group compared to the control group. There was also a 
reduction in antibiotics used due to acute throat infections. The authors conclude that an 
integrative treatment approach in which SilAtro-5-90 or Tonsilotren® is given alongside 
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mainstream symptomatic treatment could be of therapeutic benefit to patients with a 
history of RT.
Both small and large-scale studies suggest that homeopathy may reduce the prescribing 
of antibiotics for acute URTIs and their sequelae. 29,85,103,104 As part of an EPI3 
nationwide survey of primary care practice in France, the progress of 518 adults and 
children with URTIs (79.3% with rhinopharyngitis) treated by either GPs certified to use 
homeopathy (GP-Hom) or GPs who used conventional medicine only (GP-CM) was 
compared. Patients in the GP-Hom group showed significantly lower consumption of 
antibiotics (odds ratio (OR) = 0.43, 95% confidence interval (CI): 0.27–0.68) and 
antipyretic/anti-inflammatory drugs (OR = 0.54, 95% CI: 0.38–0.76) with similar 
outcomes. 95
Prophylactic and long term effects 
CAM therapies that are proven safe can be used to strengthen the self-healing capacities 
of the organism (preventive and curative health promotion). 105 A number of studies 
examined for this review suggest prophylactic, as well as short term potential for the 
products or remedies under review. In Siqueira et al’s (2016) 87 trial, 600 children aged 1-
5 years were randomly distributed to three groups and prescribed either a homeopathic 
complex, placebo or InfluBio. The number of flu and acute respiratory infections in each 
group in a year (2009-2010) was then recorded. While the number of episodes overall 
was small, 30.5% of the placebo group developed three or more acute infections in the 
post-intervention year whereas there were no recorded episodes in those receiving the 
homeopathic complex and only one episode in the group receiving InfluBio. A 2016 
observational study by Beghi et al (2016)74 conducted over a 10-year period in Italy 
suggested that the regular use of the homeopathic medicine Oscillococcinum® during the 
winter months could play as role in the prevention of respiratory tract infections. In 
comparison with the control group, patients who took Oscillococcinum® once a week for 
8 months per year had a greater reduction in the average infectious episodes during the 
study compared to the year before inclusion independent of age and class. 
14
An observational study from 1998 to 2008 by Rossi et al (2010)80 assessed the outcome 
of homeopathic treatment in 551 children under 14 years of age. Respiratory infections 
(337 cases; 61%) were the most frequently observed diseases. The Glasgow Homeopathic 
Hospital Outcome Score (GHHOS) was used to assess outcome. After homeopathic 
treatment, 68% of children with respiratory disease showed a strong improvement or 
attained a resolution of their problems. They conclude that improvement or resolution of 
symptoms is more likely in patients with problems in the upper respiratory tract than 
other categories (e.g. dermatological, digestion psychological) and in patients followed 
up for at least 12 months. 
Another observational study by Witt et al (2009) 99 showed long term improvements in 
patients seeking homeopathic treatment for sinusitis. The treatment group (a subgroup of 
a large multi-centred observational study) included 134 adults treated by 62 physicians. 
All patients had suffered from chronic sinusitis for over 9 years almost all (97.0%) of     
who had previously been treated with conventional medicine. Self-reported scores 
showed both physical and mental improvements persisting for 8 years. The authors point 
to the need for more explanatory studies to establish the extent to which these effects 
could be due to life-style regulation, placebo, or context effects associated with the 
treatment. Also of interest is a multicentre observational study carried out in India by 
Nayak et al (2012) 97  which sought to test the therapeutic usefulness of homeopathic 
medicine in the management of chronic sinusitis (CS) on 550 patients. The chronic 
sinusitis assessment score (CSAS) was used to assess symptom severity. The authors of 
this study found statistically significant reductions in CSAS after 3 and 6 months of 
treatment, along with improved radiological appearance. No complications were 
observed during treatment. Their conclusion is that homeopathic treatment could be 
effective for CS patients but controlled trials were required for further validation.
Combination versus single homeopathic remedies
The studies featured in this review adopt a range of approaches to prescribing, both from 
the perspective of control and selection of single or combination remedies with varying 
constituents (see table 2). Of the 7 RCTs in this review using combination remedies, 4 
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where placebo controlled. The active controls used in the other two studies varied; 
Thinesse-Mallwitz et al’s team 29,76 compared treatment with the homeopathic medication 
Influcid with standard treatment, while Jong et al 81 compared CalSuli with another 
complex homeopathic product. Siqueira et al 87 used placebo, but also compared the 
product InfluBio (purified influenza virus x 30c) with a homeopathic nosode complex  
Streptococcus, Staphylococcus and inactivated influenza virus x 30c. 
The constituents contained in the homeopathic complexes (most of them brand-named 
products) cover a wide range of remedies. Many of these remedies are derived from plant 
sources, and their propensity to alleviate or resolve the symptoms of URTIs and their 
complications have been discussed at length in the homeopathic clinical literature. 
Homeopathic compounds and syrups contained up to nine different constituents, 
generally in low potencies. 76,81,106–108 Despite wide variations in the remedies chosen, 
some clear ‘favourites’ emerged, the most commonly used remedies being Bryonia (6 
studies), Phosphorus (4 studies), Ipecachuana (4 studies) and Sulphur (3 studies). 
The findings from this review suggest at least equivalence between complex homeopathy 
and conventional treatment for uncomplicated cases of URTI. In all but one study, the 
homeopathic products under evaluation yielded favourable results by way of milder 
symptoms and shorter duration of acute illness, and several had led to reduced use of 
antibiotics. Given the ease and convenience of this type of prescribing, the distress   
associated with acute URTIs, 102 the need to reduce reliance on antibiotics and the known 
side effects of pharmaceutical OTC products, there is a case for using tried and tested 
combination remedies to treat uncomplicated cases of URTIs. On the other hand, the 
quality of the body of evidence on non-individualised homeopathic treatment is low, and 
the risk of bias in existing RCTs is high. 66 The variable constituents of each product 
(some of which contained 8 or more homeopathic ingredients) call into question the 
specific action of these products on URTIs, especially given the short lived nature of this 
condition in otherwise healthy children and adults. In addition, some products such as 
Engystol® have been tested in several studies with different results. 66,88,109 It is important 
that combination remedies continue to be subject to rigorous trials, which test the efficacy 
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and safety of such compounds. 29,76,81 Dose frequency and duration of use also need to be 
considered to eliminate accidental provings or remedy ‘exhaustion’.1 Acute illnesses 
produce different symptoms in patients, and more research is required to establish which 
products suit particular scenarios and at which stage of illness they are most effective. 
Mathie et al’s recently published paper suggests that the model validity of placebo-
controlled trials of non-individualised homeopathic treatment is lower than that of 
individualised treatment. 110 In a follow up paper, the authors conclude that better 
designed and more rigorous RCTs are needed in order to develop an evidence base that 
can decisively provide reliable effect estimates of non-individualised homeopathic 
treatment 66 , however neither individualised nor non-individualised RCT trials featuring 
homeopathy score highly in terms of risk of model validity and risk of bias. 
Conclusions 
With the emergence of AMR, respiratory infections have become more difficult to treat. 
Inappropriate use of antibiotics and other antimicrobials leads to the growth and spread of 
resistant bacteria, which colonise the airways and can affect the entire community. 91 The 
push to limit AMR requires a consolidated, concerted effort by multiple stakeholders. 111   
Effective strategies are needed to restrict the use of antibiotics without harming those 
who truly need these medications. While life style and nutrition play a significant part in 
their control, homeopathy presents a low cost, holistic adjunct or alternative for many 
common infections. The clinical trials examined in this paper showed variations in size, 
location, cohort types, type of intervention and outcome measures, which makes 
comparisons and generalisations problematic. Nevertheless, combined evidence from 
these and other studies suggest that homeopathic treatment can exert biological effects 
with fewer adverse events and broader therapeutic opportunities than conventional 
medicine in the treatment of URTIs. 58,112 Given the cost implications of treating UTRIs 
and their complications in children, and the relative absence of effective alternatives 
without potential side effects, the use of non-individualised homeopathic compounds 
1 The term ‘remedy exhaustion’ refers to the possibility that a remedy or compound might lose its 
initial efficacy if repeated too often and for too long. 
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tailored for the pediatric population merits further investigation, including through larger 
scale cohort studies. 
The quantity of peer reviewed homeopathic research is small when compared to 
conventional medicinal research. There are many gaps in evidence, but recent studies 
support the view that homeopathy could be at least as effective as a standard treatment, 
with effects which can be differentiated from placebo 113,114 and can fill existing 
effectiveness gaps in the conventional medical treatment of URTIs and their 
complications. 9 Importantly for global health, studies such as those presented in this 
paper suggest that patients given homeopathic treatment and who follow sensible disease 
avoidance measures, may avoid infections, or may be able to reduce reliance on 
conventional medication, including antibiotics. 9, 95. In the meantime, the most important 
evidence still arises from practical clinical experience and from the successful treatment 
of millions of patients. 
With the advent of antimicrobial resistance, homeopathy would appear to have a role to 
play both in offering alternative treatment for URTIs, and the possibility of the 
prevention of recurring infections associated with the upper respiratory tract. Further 
research is required to establish the best means of achieving this, however prioritizing 
studies of pediatric and elderly populations would seem a path forward for the reduction 
of antibiotic use and the on-going risk of resistance.
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